Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Probabilistic-based Learning for Joint Light Field Image Compression and Enhancement under Low-Light Conditions.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2026
Same author

Outpatient step-up dosing of bispecific antibodies in relapsed or refractory multiple myeloma: an oncology nursing framework for monitoring and supportive care.

Frontiers in oncology·2026
Same author

DCPM-ADMET: fusion of dual-component pre-trained model and molecular fingerprints to enhance drug ADMET properties prediction.

Journal of cheminformatics·2026
Same author

Optimization of Litsea cubeba ethanol extract and its antibacterial mechanism against Staphylococcus aureus.

Scientific reports·2026
Same author

Immunogenicity and safety of co-administered <i>Escherichia coli</i>-produced bivalent HPV-16/18 vaccine and hepatitis E vaccine.

Frontiers in immunology·2026
Same author

CL-316243 facilitates stable atherosclerotic plaque phenotypes in association with suppression of perivascular adipose tissue ferroptosis via upregulating C/EBPβ.

Redox biology·2026

Related Experiment Video

Updated: Jul 27, 2025

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
08:33

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

11.8K

Lung inflammation perturbation by engineered nanoparticles.

Xiaofei Zhou1, Weitao Jin1, Jingjun Ma1

  • 1College of Science and Technology, Hebei Agricultural University, Cangzhou, China.

Frontiers in Bioengineering and Biotechnology
|June 12, 2023
PubMed
Summary
This summary is machine-generated.

Nanoparticles, while useful, pose risks to lung health. This review details how nanoparticles activate and aggravate lung inflammation, and how drug-loaded nanoparticles may inhibit it.

Keywords:
biosafety evaluationlung inflammationmechanismsnanoparticlesphysicochemical properties

More Related Videos

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

5.2K
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.5K

Related Experiment Videos

Last Updated: Jul 27, 2025

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
08:33

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

11.8K
Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

5.2K
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.5K

Area of Science:

  • Environmental Health
  • Toxicology
  • Nanotechnology

Background:

  • Nanoparticles exhibit unique properties driving widespread application.
  • Understanding environmental health risks, particularly pulmonary effects, is crucial.
  • Current research on nanoparticle-induced lung inflammation is incomplete.

Purpose of the Study:

  • To review recent advancements in understanding the pulmonary toxic effects of nanoparticles.
  • To summarize nanoparticle-induced disturbances in the pulmonary inflammatory response.
  • To highlight knowledge gaps and future research directions.

Main Methods:

  • Literature review focusing on pulmonary inflammatory responses to nanoparticles.
  • Analysis of nanoparticle activation and aggravation of lung inflammation.
  • Examination of nanoparticle-drug delivery systems for anti-inflammatory effects.
  • Discussion on the influence of nanoparticle physicochemical properties on pulmonary inflammation.

Main Results:

  • Nanoparticles can activate and aggravate lung inflammation.
  • Nanoparticles loaded with anti-inflammatory drugs show potential for inhibiting inflammation.
  • Physicochemical properties significantly influence nanoparticle-induced pulmonary inflammatory responses.

Conclusions:

  • Nanoparticles pose significant risks to lung health via inflammatory pathways.
  • Further research is needed to fully elucidate mechanisms and develop mitigation strategies.
  • Targeted nanoparticle-based therapies offer potential for managing lung inflammation.